Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
The Journal of General Virology|February 7, 2022
Untying relaxed circular DNA of hepatitis B virus by polymerase reaction provides a new option for accurate quantification and visualization of covalently closed circular DNANaohiro Kamiya, Takahiko Sugimoto, Hiromi Abe-Chayama, et al.
Digestive Diseases and Sciences|May 22, 2020
Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune PancreatitisAyami Fukiage, Hatsue Fujino, Daiki Miki, et al.
Clinical Journal of Gastroenterology|October 24, 2024
A case of complete response to radiotherapy combined with durvalumab and tremelimumab in a patient with unknown primary hepatocellular carcinoma arising in the lumbar spineAiko Tanaka, Tomokazu Kawaoka, Shinsuke Uchikawa, et al.
Clinical Journal of Gastroenterology|July 14, 2020
Real-word efficacy of sofosbuvir, velpatasvir plus ribavirin therapy for chronic hepatitis patients who failed to prior DAA therapy with NS5A-P32 deletion mutated HCV infectionShintaro Takaki, Michio Imamura, Shuji Yamaguchi, et al.
Clinical Journal of Gastroenterology|May 4, 2026
Durvalumab and tremelimumab combination therapy achieved remarkable response in primary hepatic undifferentiated carcinoma with high PD-L1 expressionMichihiko Kawahara, Hatsue Fujino, Yasutoshi Fujii, et al.
European Journal of Human Genetics : EJHG|March 1, 2026
A prioritization framework for BRCA1/2 variants of uncertain significance identified by comprehensive genomic profilingHikaru Nakahara, Hiroaki Niitsu, Asuka Toshida, et al.
BMC Gastroenterology|September 26, 2020
Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infectionNaoyuki Ueda, Tomokazu Kawaoka, Michio Imamura, et al.
Gastroenterology|July 20, 2010
ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patientsHidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2015
Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patientsEisuke Miyaki, Michio Imamura, Nobuhiko Hiraga, et al.
The American Journal of Pathology|March 21, 2015
Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized miceYuji Ishida, Chihiro Yamasaki, Ami Yanagi, et al.
Pageof 18